Lista de obras - Mario Roselli - Dominio Público Uruguay

A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes

artículo científico publicado en 2012

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.

artículo científico publicado en 2013

Aging: an important risk factor in chemotherapy-associated vascular diseases

artículo científico publicado en 2013

An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients

scientific article published on 28 February 2011

An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies

article

Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies

artículo científico publicado en 2012

Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'.

artículo científico publicado en 2015

Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer

artículo científico publicado en 2012

Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer

artículo científico publicado en 2012

Cardiac sarcomas: an update.

artículo científico publicado en 2010

Caregiver distress in the early phases of cancer.

artículo científico publicado en 2010

Clinical models and biochemical predictors of VTE in lung cancer

artículo científico publicado en 2014

Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.

artículo científico publicado en 2010

Determinants of homocysteine levels in colorectal and breast cancer patients.

artículo científico publicado en 2009

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?

artículo científico publicado en 2018

Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients—a pilot study

artículo científico publicado en 2012

Effects of conventional therapeutic interventions on the number and function of regulatory T cells.

scientific article published on October 2013

Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle

artículo científico

Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy

artículo científico publicado en 2014

Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy

artículo científico publicado en 2014

Family history of cancer in patients with gastric cancer

artículo científico publicado en 2012

Immune reaction and colorectal cancer: friends or foes?

artículo científico publicado en 2014

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

artículo científico publicado en 2020

Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.

artículo científico

Impact of chemotherapy on activated protein C-dependent thrombin generation-Association with VTE occurrence

artículo científico publicado en 2013

Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study

artículo científico publicado en 2013

Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass.

artículo científico publicado en 2015

Increased Risk of Chemotherapy-Associated Venous Thromboembolism in Elderly Patients with Cancer

artículo científico publicado en 2013

Insulinemia and the risk of breast cancer and its relapse.

artículo científico publicado en 2012

Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.

artículo científico

Monoclonal antibodies in gastrointestinal cancers.

artículo científico

Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes

artículo científico publicado el 1 de mayo de 2013

Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients

artículo científico publicado en 2012

Obesity and colorectal cancer: role of adipokines in tumor initiation and progression

artículo científico publicado en 2014

Obesity-driven inflammation and colorectal cancer.

artículo científico publicado en 2012

Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

artículo científico publicado en 2014

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

artículo científico publicado en 2018

Perianal Paget's disease: a case report and literature review

artículo científico publicado el 1 de octubre de 2012

Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B).

artículo científico publicado en 2013

Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors

artículo científico publicado en 2014

Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia

artículo científico publicado en 2014

Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome

Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention

artículo científico publicado en 2011

Pleiotropic effects of PPARγ agonist on hemostatic activation in type 2 diabetes mellitus.

artículo científico publicado en 2013

Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy.

artículo científico publicado en 2014

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab ⬇️

artículo científico publicado el 29 de diciembre de 2010

Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients

scientific article published on 10 October 2012

Prognostic significance of serum adipokine levels in colorectal cancer patients

artículo científico publicado en 2009

RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank.

artículo científico publicado en 2011

Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience.

artículo científico publicado en 2010

Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases.

artículo científico

SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling - effective exchange and search of stored biospecimens.

artículo científico publicado en 2012

Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients

artículo científico publicado en 2010

Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0‐vaccinated mice ⬇️

artículo científico publicado el 22 de diciembre de 2010

Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients

scientific article published on 23 August 2014

TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy.

artículo científico publicado en 2013

Targeted therapy in first line treatment of RAS wild type colorectal cancer.

artículo científico publicado en 2015

Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches.

artículo científico

Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress

artículo científico publicado en 2015

VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea

article

VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.

artículo científico publicado en 2015

Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.

artículo científico publicado en 2014

von Hippel Lindau disease with colon adenocarcinoma, renal cell carcinoma and adrenal pheochromocytoma.

artículo científico publicado en 2013

Lista de obras de Mario Roselli

A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.

Aging: an important risk factor in chemotherapy-associated vascular diseases

An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients

An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies

Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies

Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'.

Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer

Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer

Cardiac sarcomas: an update.

Caregiver distress in the early phases of cancer.

Clinical models and biochemical predictors of VTE in lung cancer

Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.

Determinants of homocysteine levels in colorectal and breast cancer patients.

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?

Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients—a pilot study

Effects of conventional therapeutic interventions on the number and function of regulatory T cells.

Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle

Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy

Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy

Family history of cancer in patients with gastric cancer

Immune reaction and colorectal cancer: friends or foes?

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.

Impact of chemotherapy on activated protein C-dependent thrombin generation-Association with VTE occurrence

Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study

Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass.

Increased Risk of Chemotherapy-Associated Venous Thromboembolism in Elderly Patients with Cancer

Insulinemia and the risk of breast cancer and its relapse.

Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.

Monoclonal antibodies in gastrointestinal cancers.

Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes

Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients

Obesity and colorectal cancer: role of adipokines in tumor initiation and progression

Obesity-driven inflammation and colorectal cancer.

Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

Perianal Paget's disease: a case report and literature review

Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B).

Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors

Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia

Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome

Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention

Pleiotropic effects of PPARγ agonist on hemostatic activation in type 2 diabetes mellitus.

Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy.

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab ⬇️

Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients

Prognostic significance of serum adipokine levels in colorectal cancer patients

RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank.

Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience.

Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases.

SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling - effective exchange and search of stored biospecimens.

Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients

Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0‐vaccinated mice ⬇️

Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients

TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy.

Targeted therapy in first line treatment of RAS wild type colorectal cancer.

Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches.

Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress

VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea

VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.

Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.

von Hippel Lindau disease with colon adenocarcinoma, renal cell carcinoma and adrenal pheochromocytoma.